Free Trial

Brokers Issue Forecasts for TriMas' Q1 Earnings (NASDAQ:TRS)

TriMas logo with Industrials background

Key Points

  • Zacks Research Analysts have lowered their Q1 2027 earnings per share estimates for TriMas Corporation from $0.57 to $0.52.
  • Despite the earnings estimate revision, TriMas has a current "Strong-Buy" rating from Zacks and a consensus target price of $45.00.
  • The company recently announced a quarterly dividend of $0.04 per share, reflecting an annualized yield of 0.4%.
  • Interested in TriMas? Here are five stocks we like better.

TriMas Corporation (NASDAQ:TRS - Free Report) - Zacks Research dropped their Q1 2027 earnings per share estimates for shares of TriMas in a note issued to investors on Thursday, September 4th. Zacks Research analyst Team now forecasts that the industrial products company will earn $0.52 per share for the quarter, down from their previous estimate of $0.57. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share.

Other analysts have also issued research reports about the company. KeyCorp set a $45.00 price target on TriMas and gave the company an "overweight" rating in a report on Tuesday, August 12th. BWS Financial restated a "buy" rating and set a $45.00 price target (up previously from $40.00) on shares of TriMas in a report on Wednesday, July 30th. Finally, Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $45.00.

Check Out Our Latest Research Report on TRS

TriMas Trading Down 0.5%

NASDAQ:TRS traded down $0.20 during midday trading on Monday, hitting $39.00. 616,231 shares of the company traded hands, compared to its average volume of 543,456. The firm's fifty day moving average is $35.07 and its 200-day moving average is $28.07. TriMas has a 12-month low of $19.33 and a 12-month high of $39.71. The firm has a market capitalization of $1.58 billion, a P/E ratio of 42.86 and a beta of 0.65. The company has a current ratio of 2.59, a quick ratio of 1.44 and a debt-to-equity ratio of 0.59.

TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.11. TriMas had a return on equity of 11.49% and a net margin of 3.83%.The company had revenue of $274.76 million for the quarter, compared to analyst estimates of $251.18 million. During the same quarter in the prior year, the firm posted $0.43 EPS. TriMas's quarterly revenue was up 14.2% compared to the same quarter last year. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS.

TriMas Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Stockholders of record on Tuesday, August 5th were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. TriMas's dividend payout ratio is presently 17.58%.

Institutional Investors Weigh In On TriMas

Institutional investors have recently added to or reduced their stakes in the stock. State of Wyoming bought a new stake in TriMas during the fourth quarter valued at about $50,000. BNP Paribas Financial Markets boosted its position in TriMas by 35.4% during the second quarter. BNP Paribas Financial Markets now owns 3,319 shares of the industrial products company's stock valued at $95,000 after purchasing an additional 868 shares in the last quarter. Tower Research Capital LLC TRC boosted its position in TriMas by 280.5% during the second quarter. Tower Research Capital LLC TRC now owns 4,193 shares of the industrial products company's stock valued at $120,000 after purchasing an additional 3,091 shares in the last quarter. AE Wealth Management LLC bought a new stake in TriMas during the second quarter valued at about $212,000. Finally, Tidal Investments LLC bought a new stake in TriMas during the second quarter valued at about $220,000. Institutional investors own 99.42% of the company's stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Featured Stories

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.